Rockefeller Capital Management
TNGX icon

Rockefeller Capital Management’s Tango Therapeutics TNGX Stock Holding History

Rockefeller Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
36,421
+81
+0.2% +$2K ﹤0.01% 1630
2026
Q1 		$760K Buy
36,340
+35,453
+3,997% +$493K ﹤0.01% 1748
2025
Q4 		$7.86K Buy
887
+765
+627% +$6.59K ﹤0.01% 3914
2025
Q3 		$1.02K Buy
+122
New +$826 ﹤0.01% 4186

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Rockefeller Capital Management's TNGX Position: Q2 2026 in Review

Rockefeller Capital Management increased its Tango Therapeutics (TNGX) stake by 0.22% in Q2 2026, buying an estimated $2K and bringing the position to 36,421 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1630.

Rockefeller Capital Management first reported a position in TNGX in Q3 2025 and has held it in 4 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Rockefeller Capital Management held 36,421 shares of Tango Therapeutics worth $1.14M as of Q2 2026.
  • Rockefeller Capital Management bought 81 Tango Therapeutics shares in Q2 2026, an estimated $2K.
  • Tango Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1630 holding.
  • Rockefeller Capital Management first reported a position in Tango Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.